ICM
POLY

Invenomic Capital Management’s Plantronics, Inc. POLY Stock Holding History

Invenomic Capital Management’s Portfolio POLY Stock Details POLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-53,081
Closed -$828K – 186
2020
Q2 		$779K Buy
53,081
+14,188
+36% +$185K 0.58% 62
2020
Q1 		$391K Sell
38,893
-141,649
-78% -$2.64M 0.32% 87
2019
Q4 		$4.94M Buy
+180,542
New +$5.43M 1.98% 10

Other funds holding POLY

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
SI
Sapience Investments Newport Beach, California $772K AUM 24.07% 1-Year Est. Return

Invenomic Capital Management's POLY Position: Q3 2020 in Review

Invenomic Capital Management sold out of Plantronics, Inc. (POLY) in Q3 2020, closing a stake of 53,081 shares — an estimated $828K sold.

Invenomic Capital Management first reported a position in POLY in Q4 2019 and held it in 3 quarters. The position peaked at $4.94M in Q4 2019. 150 funds tracked by Wall St. Rank hold POLY as of Q3 2020.

  • Invenomic Capital Management reported no remaining Plantronics, Inc. position as of Q3 2020 after selling out during the quarter.
  • Invenomic Capital Management sold 53,081 Plantronics, Inc. shares in Q3 2020, an estimated $828K.
  • Invenomic Capital Management first reported a position in Plantronics, Inc. in Q4 2019 and held it in 3 quarters.
  • Invenomic Capital Management's Plantronics, Inc. position peaked at $4.94M in Q4 2019.
  • 150 funds tracked by Wall St. Rank held Plantronics, Inc. as of Q3 2020.

Based on Invenomic Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.